期刊文献+

重复经颅磁刺激治疗轻中度血管性痴呆的对照研究 被引量:5

下载PDF
导出
摘要 目的:探讨重复经颅磁刺激(repetitive transcranial magnetic stimulation,rTMS)治疗轻中度血管性痴呆(vascular dementia,VD)的疗效和安全性。方法:61例患者随机分为实验组及对照组,两组均予抗血小板等常规治疗,实验组加用rTMS,频率3Hz,刺激强度为静息态阈值的100%,治疗4周后比较两组患者的治疗效果。结果:实验组总好转率高于对照组,两组患者经治疗后均有明显疗效,但实验组患者治疗效果更佳,治疗过程中未见明显不良反应。结论:rTMS治疗VD疗效确切,副作用小,值得临床推广。
出处 《实用医学杂志》 CAS 北大核心 2013年第17期2846-2847,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献10

  • 1Wang F, Geng X, Tao H Y, et al. The restoration after repetitive transcranial magnetic stimulation treatment on cognitive ability of vaseular dementia rats and its impacts on synaptie plastieity in hippocampal CA1 area[J].J Mol Neurosei, 2010,41 ( 1 ), 145-155.
  • 2Onesti E, Gabriele M, Cambieri C, et al. H-coil repetitive transcranial magnetic stimulation? for pain relief in patients with diabetic neuropathy [Jl. Eur J Pain, 2013, doi: 10.1002/j. 1532-2149.2013.00320.x.
  • 3Wassermann E M, Lisanby S H. Therapeutic application of repetitive transeranial magnetic stimulation: a review[J]. Clin Ncurophysiol, 2001 (112) : 1367-1377.
  • 4Torii T, Sato A, Nakahara Y, et al. Frequeney-dependent effects of repetitive transeranial magnetic stimulation on the human brain [ J ]. Neuroreport, 2012,23 ( 18 ) : 1065 - 1070.
  • 5Kole M H, Fuchs E, Ziemann U, et al. Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats [J]. Brain Research, 1999,826(2) : 309-312.
  • 6Michael N, G~,sling M, Reatemann M, et al. Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (~H MRS) study of healthy brain [J 1. Eur J Neurosci, 2003,17 ( 11 ) : 2462-2468.
  • 7Chistyakov A V, Kaplan B, Rubichek O, et al. Antidepressant effect of different schedules of repetitive transcranial magnetic stimulation vs. clomipramine in patients with major depression: relationship to change in cortical exectiability [J]. Int J Neuropsychopharmacol, 2005,8 (2) : 223-233.
  • 8Bey A, Leue S, Wienbruch C. A neuronal network model for simulating the effects of repetitive transcranial magnetic stimulation on local field potential power spectra [J]. PLoS One, 2012,7(11):129-135.
  • 9Ahmed M A, Darwish E S, Khedr E M, et al. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia [ J ]. J Neurol, 2012,259 ( 1 ) : 83-92.
  • 10Wassermann E M. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996 [J]. Electroencephalogr Clin Neurophysiol, 1998,108( 1 ) : 1-16.

同被引文献84

  • 1龚启明,颜永宏,李岩松,仇靖.轻微认知功能障碍老年人血脂、载脂蛋白水平及临床意义[J].临床神经病学杂志,2004,17(6):452-453. 被引量:10
  • 2窦祖林 ,欧海宁 ,文伟光 ,郑金利 .无错性学习在脑损伤患者记忆功能恢复中的应用[J].中国临床康复,2005,9(16):84-87. 被引量:9
  • 3陈霞,张振馨,钱彩韻,陈生弟,洪震,杨华,赵洁皓,郭启浩,方滢滢,王瑛,温洪波.卡巴拉汀治疗血管性痴呆的开放性多中心随机对照研究[J].中华神经科杂志,2005,38(8):483-487. 被引量:8
  • 4丁新华,韩肖华,温新义,黄晓琳.电针不同穴位结合高压氧治疗脑损害认知障碍[J].中国康复,2007,22(1):29-30. 被引量:17
  • 5Korczyn AD, Vakhapova V, Grinberg LT. Vascular dementia [J]. J NeurolSei, 2012,322:2.
  • 6Woolf N J, Butcher LL. Cholinergic systems mediate action from movement to higher conseiousness[J]. Behav Brain Res, 2011,221:488.
  • 7Romdn GC, Salloway S, Black SE. Randomized, placebo-con- trolled, clinical trial of donepezil in vascular dementia: differ- ential effects by hippocampal size[J]. Stroke, 2010, 41( 6): 1213.
  • 8Erkinjuntti T, Gauthier S, Bullock R. Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial( GAL-INT-6)[J].Psychopharmacol, 2008, 22(7): 761.
  • 9Ballard C, Sauter M, Scheltens P, et al. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the vantage study[J]. Curr Med Res Opin, 2008, 24:2561.
  • 10Herrschaft H, Nacu A, Likhachev S, et al. Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric fea- tures: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg[J]. J Psychiatr Res. 2012,46(6):716.

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部